287 related articles for article (PubMed ID: 19153090)
1. Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment.
Devroey P; Aboulghar M; Garcia-Velasco J; Griesinger G; Humaidan P; Kolibianakis E; Ledger W; Tomás C; Fauser BC
Hum Reprod; 2009 Apr; 24(4):764-74. PubMed ID: 19153090
[TBL] [Abstract][Full Text] [Related]
2. Comparisons of GnRH antagonist versus GnRH agonist protocol in poor ovarian responders undergoing IVF.
Pu D; Wu J; Liu J
Hum Reprod; 2011 Oct; 26(10):2742-9. PubMed ID: 21778283
[TBL] [Abstract][Full Text] [Related]
3. GnRH antagonist rescue of a long-protocol IVF cycle and GnRH agonist trigger to avoid ovarian hyperstimulation syndrome: three case reports.
Martínez F; Rodríguez DB; Buxaderas R; Tur R; Mancini F; Coroleu B
Fertil Steril; 2011 Jun; 95(7):2432.e17-9. PubMed ID: 21513932
[TBL] [Abstract][Full Text] [Related]
4. [Onset and maintenance of the luteal phase with GnRH agonists or hCG in cycles under GnRH antagonists].
Olivennes F
J Gynecol Obstet Biol Reprod (Paris); 2004 Oct; 33(6 Pt 2):3S24-6. PubMed ID: 15643682
[TBL] [Abstract][Full Text] [Related]
5. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle.
Kahraman K; Berker B; Atabekoglu CS; Sonmezer M; Cetinkaya E; Aytac R; Satiroglu H
Fertil Steril; 2009 Jun; 91(6):2437-44. PubMed ID: 18555238
[TBL] [Abstract][Full Text] [Related]
6. GnRH antagonists in ovarian stimulation for IVF.
Tarlatzis BC; Fauser BC; Kolibianakis EM; Diedrich K; Rombauts L; Devroey P
Hum Reprod Update; 2006; 12(4):333-40. PubMed ID: 16567347
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antagonist-treated ovarian stimulation cycles.
Tesarik J; Hazout A; Mendoza-Tesarik R; Mendoza N; Mendoza C
Hum Reprod; 2006 Oct; 21(10):2572-9. PubMed ID: 16926261
[TBL] [Abstract][Full Text] [Related]
8. GnRH agonist and GnRH antagonist in intracytoplasmic injection cycles.
Rashid MR; Ong FB; Omar MH; Ng SP; Nurshaireen A; Sharifah-Teh NS; Fazilah AH; Zamzarina MA
Med J Malaysia; 2008 Jun; 63(2):113-7. PubMed ID: 18942295
[TBL] [Abstract][Full Text] [Related]
9. Comparison of GnRH antagonist protocol with or without oral contraceptive pill pretreatment and GnRH agonist low-dose long protocol in low responders undergoing IVF/intracytoplasmic sperm injection.
Kim CH; Jeon GH; Cheon YP; Jeon I; Kim SH; Chae HD; Kang BM
Fertil Steril; 2009 Nov; 92(5):1758-60. PubMed ID: 19523618
[TBL] [Abstract][Full Text] [Related]
10. Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm injection treatment cycle: impact on ovarian stimulation. A pilot study.
Blockeel C; Riva A; De Vos M; Haentjens P; Devroey P
Fertil Steril; 2011 Apr; 95(5):1714-9.e1-2. PubMed ID: 21300334
[TBL] [Abstract][Full Text] [Related]
11. The optimal length of 'coasting protocol' in women at risk of ovarian hyperstimulation syndrome undergoing in vitro fertilization.
Nardo LG; Cheema P; Gelbaya TA; Horne G; Fitzgerald CT; Pease EH; Brison DR; Lieberman BA
Hum Fertil (Camb); 2006 Sep; 9(3):175-80. PubMed ID: 17008270
[TBL] [Abstract][Full Text] [Related]
12. [Coasting and ovarian stimulation protocols in high-responder patients undergoing assisted conception].
Merviel P; Claeys C; Héraud MH; Lourdel E; Lanta S; Barbier F; Nasreddine A
Gynecol Obstet Fertil; 2005 Sep; 33(9):703-12. PubMed ID: 16129645
[TBL] [Abstract][Full Text] [Related]
13. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
Weitzman VN; Engmann L; DiLuigi A; Maier D; Nulsen J; Benadiva C
Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961
[TBL] [Abstract][Full Text] [Related]
14. Gonadotropin-releasing hormone (GnRH) antagonist plus recombinant luteinizing hormone vs. a standard GnRH agonist short protocol in patients at risk for poor ovarian response.
De Placido G; Mollo A; Clarizia R; Strina I; Conforti S; Alviggi C
Fertil Steril; 2006 Jan; 85(1):247-50. PubMed ID: 16412769
[TBL] [Abstract][Full Text] [Related]
15. Comparison of GnRH agonists and antagonists in normoresponder IVF/ICSI in Turkish female patients.
Moraloglu O; Kilic S; Karayalçin R; Yuksel B; Tasdemir N; Işik A; Ugur M
Adv Ther; 2008 Mar; 25(3):266-73. PubMed ID: 18345521
[TBL] [Abstract][Full Text] [Related]
16. [Biological assessment criteria during antagonist protocols].
Plachot M
J Gynecol Obstet Biol Reprod (Paris); 2004 Oct; 33(6 Pt 2):3S32-5. PubMed ID: 15643685
[TBL] [Abstract][Full Text] [Related]
17. [Research on the protocol of limited ovarian stimulation to prevent ovarian hyperstimulation syndrome].
Zhu YM; Gao HJ; He RH; Huang HF
Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):740-4. PubMed ID: 17327030
[TBL] [Abstract][Full Text] [Related]
18. [What is mild stimulation?].
Merviel P; Lourdel E; Cabry R; Boulard V; Scheffler F; Dupond S; Lombart M; Marc C
Gynecol Obstet Fertil; 2012 Sep; 40(9):467-71. PubMed ID: 22920234
[TBL] [Abstract][Full Text] [Related]
19. GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity.
Orvieto R; Meltzer S; Rabinson J; Zohav E; Anteby EY; Nahum R
Fertil Steril; 2008 Oct; 90(4):1294-6. PubMed ID: 18178197
[TBL] [Abstract][Full Text] [Related]
20. GnRH antagonist pre-treatment: one centre's experience for IVF-ICSI cycle scheduling.
Viardot-Foucault V; Nadarajah S; Lye WK; Tan HH
Reprod Biomed Online; 2015 Apr; 30(4):366-72. PubMed ID: 25684093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]